{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:25:51Z","timestamp":1787682351673,"version":"build-2784847793"},"reference-count":72,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870017"],"award-info":[{"award-number":["31870017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Department of Science and Technology of Yunnan Province","doi-asserted-by":"publisher","award":["2018FY001(-006)"],"award-info":[{"award-number":["2018FY001(-006)"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>SARS-CoV-2, which emerged in Wuhan, China, is a new global\nthreat that has killed millions of people and continues to do so. This pandemic has not only\nthreatened human life but has also triggered economic downturns across the world. Researchers\nhave made significant strides in discovering molecular insights into SARSCoV-\n2 pathogenesis and developing vaccines, but there is still no successful cure for\nSARS-CoV-2 infected patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The present study has proposed a drug-repositioning pipeline for the design\nand discovery of an effective fungal-derived bioactive metabolite as a drug candidate\nagainst SARS-CoV-2.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Fungal derivative \u201cCordycepin\u201d was selected for this study to investigate the\ninhibitory properties against RNA-dependent RNA polymerase (RdRp) (PDB ID: 6M71)\nof SARS-CoV-2. The pharmacological profile, intermolecular interactions, binding energy,\nand stability of the compound were determined utilizing cheminformatic approaches.\nSubsequently, molecular dynamic simulation was performed to better understand the\nbinding mechanism of cordycepin to RdRp.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The pharmacological data and retrieved molecular dynamics simulations trajectories\nsuggest excellent drug-likeliness and greater structural stability of cordycepin,\nwhile the catalytic residues (Asp760, Asp761), as well as other active site residues\n(Trp617, Asp618, Tyr619, Trp800, Glu811) of RdRp, showed better stability during the\noverall simulation span.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Promising results of pharmacological investigation along with molecular\nsimulations revealed that cordycepin exhibited strong inhibitory potential against SARSCoV-\n2 polymerase enzyme (RdRp). Hence, cordycepin should be highly recommended to\ntest in a laboratory to confirm its inhibitory potential against the SARS-CoV-2 polymerase\nenzyme (RdRp).<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867328666210820114025","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T04:40:40Z","timestamp":1629693640000},"page":"152-162","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent\nRNA Polymerase (RdRp)"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9585-9042","authenticated-orcid":true,"given":"Shabana","family":"Bibi","sequence":"first","affiliation":[{"name":"Yunnan Herbal Laboratory, College of Ecology and Environmental Sciences, Yunnan University, Kunming 650091, Yunnan,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-889X","authenticated-orcid":true,"given":"Mohammad Mehedi","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail 1902,Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3305-9418","authenticated-orcid":true,"given":"Yuan-Bing","family":"Wang","sequence":"additional","affiliation":[{"name":"Yunnan Herbal Laboratory, College of Ecology and Environmental Sciences, Yunnan University, Kunming 650091, Yunnan,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1583-1125","authenticated-orcid":true,"given":"Stavros P.","family":"Papadakos","sequence":"additional","affiliation":[{"name":"First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens (NKUA), Athens,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2149-5714","authenticated-orcid":true,"given":"Hong","family":"Yu","sequence":"additional","affiliation":[{"name":"Yunnan Herbal Laboratory, College of Ecology and Environmental Sciences, Yunnan University, Kunming 650091, Yunnan,China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jama.2020.1097","volume":"323","author":"Phelan A.L.","year":"2020","unstructured":"Phelan A.L.; Katz R.; Gostin L.O.; The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA 2020,323(8),709-710","journal-title":"JAMA"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/0022034520914246","volume":"99","author":"Meng L.","year":"2020","unstructured":"Meng L.; Hua F.; Bian Z.; Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. J Dent Res 2020,99(5),481-487","journal-title":"J Dent Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"m408","DOI":"10.1136\/bmj.m408","volume":"368","author":"Mahase E.","year":"2020","unstructured":"Mahase E.; China coronavirus: WHO declares international emergency as death toll exceeds 200. BMJ 2020,368,m408","journal-title":"BMJ"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"Wu C.","year":"2020","unstructured":"Wu C.; Liu Y.; Yang Y.; Zhang P.; Zhong W.; Wang Y.; Wang Q.; Xu Y.; Li M.; Li X.; Zheng M.; Chen L.; Li H.; Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 2020,10(5),766-788","journal-title":"Acta Pharm Sin B"},{"key":"ref=5","volume":"11","author":"Khalaf K.","year":"2020","unstructured":"Khalaf K.; Papp N.; Chou J.TT.; Hana D.; Mackiewicz A.; Kaczmarek M.; SARS-CoV-2: Pathogenesis, and advancements in diagnostics and treatment. Frontiers in Immunology. Frontiers Media SA 2020,11","journal-title":"Frontiers Media SA"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/17476348.2020.1778470","volume":"14","author":"Robba C.","year":"2020","unstructured":"Robba C.; Battaglini D.; Pelosi P.; Rocco P.RM.; Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Review of Respiratory Medicine 2020,14,865-868","journal-title":"Expert Review of Respiratory Medicine"},{"key":"ref=7","unstructured":"CDC COVID Data Tracker. Available from: https:\/\/covid.cdc.gov\/covid-data-tracker\/#datatracker-home"},{"key":"ref=8","unstructured":"WHO Coronavirus (COVID-19) Dashboard. Available from: https:\/\/covid19.who.int\/"},{"key":"ref=9","unstructured":"Map and charts showing the spread of the novel coronavirus. Available from:  https:\/\/graphics.reuters.com\/CHINA-HEALTH-MAP\/0100B59S39E\/index.html"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.arcmed.2020.09.010","volume":"52","author":"Ita K.","year":"2020","unstructured":"Ita K.; Coronavirus DIsease (COVID-19): Current status and prospects for drug and vaccine development. Arch Med Res 2020,52(1),15-24","journal-title":"Arch Med Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","volume":"182","author":"Wang Q.","year":"2020","unstructured":"Wang Q.; Wu J.; Wang H.; Gao Y.; Liu Q.; Mu A.; Ji W.; Yan L.; Zhu Y.; Zhu C.; Fang X.; Yang X.; Huang Y.; Gao H.; Liu F.; Ge J.; Sun Q.; Yang X.; Xu W.; Liu Z.; Yang H.; Lou Z.; Jiang B.; Guddat L.W.; Gong P.; Rao Z.; Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase. Cell 2020,182(2),417-428.e13","journal-title":"Cell"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7423","volume":"12","author":"Pal M.","year":"2020","unstructured":"Pal M.; Berhanu G.; Desalegn C.; Kandi V.; Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus 2020,12(3)","journal-title":"Cureus"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.7150\/ijbs.45053","volume":"16","author":"Zheng J.","year":"2020","unstructured":"Zheng J.; SARS-coV-2: An emerging coronavirus that causes a global threat. Int J Biol Sci 2020,16(10),1678-1685","journal-title":"Int J Biol Sci"},{"key":"ref=14","unstructured":"Betacoronavirus - an overview | ScienceDirect Topics. Available from: https:\/\/www.sciencedirect.com\/topics\/ immunology-and-microbiology\/betacoronavirus"},{"key":"ref=15","author":"Naqvi A.A.T.","unstructured":"Naqvi A.A.T.; Fatima K.; Mohammad T.; Fatima U.; Singh I.K.; Singh A.;  nsights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. In: Biochimica et Biophysica Acta - Molecular Basis of Disease; Elsevier B.V., 2020; 1866, p. 165878."},{"key":"ref=16","author":"Yan R.","unstructured":"Yan R.; Zhang Y.; Li Y.; Xia L.; Guo Y.; Zhou Q.;  Structural basis for the recognition of SARS-CoV-2 by fulllength human ACE2. Science (80- ), 2020, 367(6485), 1444-1448. Available from: http:\/\/science.sciencemag.org\/"},{"key":"ref=17","author":"Hu B.","unstructured":"Hu B.; Guo H.; Zhou P.; Shi Z.L.;  Characteristics of SARS-CoV-2 and COVID-19In: Nature Reviews Microbiology;\nNature Research, 2020; 19, pp 141-154 Available from:  www.nature.com\/nrmicro","journal-title":"Characteristics of SARS-CoV-2 and COVID-19In: Nature Reviews Microbiology;\nNature Research, 2020; 19, pp 141-154 Available from:"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1080\/07391102.2020.1754293","volume":"39","author":"Hasan A.","year":"2020","unstructured":"Hasan A.; Paray B.A.; Hussain A.; Qadir F.A.; Attar F.; Aziz F.M.; A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J Biomol Struct Dyn 2020,39(8),3025-3033","journal-title":"J Biomol Struct Dyn"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/cells9051267","volume":"9","author":"Romano M.","year":"2020","unstructured":"Romano M.; Ruggiero A.; Squeglia F.; Maga G.; Berisio R.; A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells 2020,9(5),1267","journal-title":"Cells"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12985-020-01402-1","volume":"17","author":"Michel C.J.","year":"2020","unstructured":"Michel C.J.; Mayer C.; Poch O.; Thompson J.D.; Characterization of accessory genes in coronavirus genomes. Virol J 2020,17(1),131","journal-title":"Virol J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/jmv.24736","volume":"89","author":"Elfiky A.A.","year":"2017","unstructured":"Elfiky A.A.; Mahdy S.M.; Elshemey W.M.; Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses. J Med Virol 2017,89(6),1040-1047","journal-title":"J Med Virol"},{"key":"ref=22","author":"Gao Y.","unstructured":"Gao Y.; Yan L.; Huang Y.; Liu F.; Zhao Y.; Cao L.;  Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science (80- ), 2020, 368(6492), 779-82."},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2020.08.116","volume":"538","author":"Jiang Y.","year":"2020","unstructured":"Jiang Y.; Yin W.; Xu, HE RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19. Biochem Biophys Res Commun 2020,538,47","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1038\/s41467-019-10280-3","volume":"10","author":"Kirchdoerfer R.N.","year":"2019","unstructured":"Kirchdoerfer R.N.; Ward A.B.; Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun 2019,10(1),2342","journal-title":"Nat Commun"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.26359.1","author":"Baby K.","year":"2020","unstructured":"Baby K.; Maity S.; Mehta C.H.; Suresh A.; Nayak U.Y.; Nayak Y.; Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19. F1000 Research 9, 1166.2020"},{"key":"ref=26","author":"Appleby TC","unstructured":"Appleby TC; Perry JK; Murakami E; Barauskas O; Feng J;  J; Cho, A Structural basis for RNA replication by the hepatitis C virus polymerase. Science (80-), 2015, 347(6223), 771-775."},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"22505","DOI":"10.1073\/pnas.1007626107","volume":"107","author":"Gong P.","year":"2010","unstructured":"Gong P.; Peersen O.B.; Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc Natl Acad Sci USA 2010,107(52),22505-22510","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/jmv.24678","volume":"88","author":"Elfiky A.A.","year":"2016","unstructured":"Elfiky A.A.; Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials. J Med Virol 2016,88(12),2044-2051","journal-title":"J Med Virol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2217\/fvl-2017-0081","volume":"12","author":"Elfiky A.A.","year":"2017","unstructured":"Elfiky A.A.; Zika virus: novel guanosine derivatives revealed strong binding and possible inhibition of the polymerase. Future Virol 2017,12(12),721-728","journal-title":"Future Virol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1573406414666181015152511","volume":"15","author":"Elfiky A.A.","year":"2019","unstructured":"Elfiky A.A.; Novel guanosine derivatives as anti-HCV NS5b polymerase: a QSAR and molecular docking study. Med Chem 2019,15(2),130-137","journal-title":"Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117592","volume":"253","author":"Elfiky A.A.","year":"2020","unstructured":"Elfiky A.A.; Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci 2020,253","journal-title":"Life Sci"},{"key":"ref=32","author":"Yin W.","unstructured":"Yin W.; Mao C.; Luan X.; Shen D.D.; Shen Q.; Su H.;  Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science (80- ), 2020, 368(6498), 1499-504."},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12967-020-02439-0","volume":"18","author":"Aftab S.O.","year":"2020","unstructured":"Aftab S.O.; Ghouri M.Z.; Masood M.U.; Haider Z.; Khan Z.; Ahmad A.; Munawar N.; Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach. J Transl Med 2020,18(1),275","journal-title":"J Transl Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/1573406416666191227120425","volume":"17","author":"Bibi S.","year":"2021","unstructured":"Bibi S.; Wang Y-B.; Tang D-X.; Kamal M.A.; Yu H.; Prospects for discovering the secondary metabolites of Cordyceps sensu lato by the integrated strategy. Med Chem 2021,17(2),97-120","journal-title":"Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.2042-7158.2012.01601.x","volume":"65","author":"Yue K.","year":"2013","unstructured":"Yue K.; Ye M.; Zhou Z.; Sun W.; Lin X.; The genus Cordyceps: a chemical and pharmacological review. J Pharm Pharmacol 2013,65(4),474-493","journal-title":"J Pharm Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/575063","volume":"2015","author":"Liu Y.","year":"2015","unstructured":"Liu Y.; Wang J.; Wang W.; Zhang H.; Zhang X.; Han C.; The chemical constituents and pharmacological actions of Cordyceps sinensis. Evid Based Complement Alternat Med 2015,2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218449","volume":"14","author":"Huang F.","year":"2019","unstructured":"Huang F.; Li W.; Xu H.; Qin H.; He Z-G.; Cordycepin kills Mycobacterium tuberculosis through hijacking the bacterial adenosine kinase. PLoS One 2019,14(6)","journal-title":"PLoS One"},{"key":"ref=38","author":"Ashraf S.A.","unstructured":"Ashraf S.A.; Elkhalifa A.E.O.; Siddiqui A.J.; Patel M.; Awadelkareem A.M.; Snoussi M.;"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1261\/rna.1458909","volume":"15","author":"Holbein S.","year":"2009","unstructured":"Holbein S.; Wengi A.; Decourty L.; Freimoser F.M.; Jacquier A.; Dichtl B.; Cordycepin interferes with 3\u2032 end formation in yeast independently of its potential to terminate RNA chain elongation. RNA 2009,15(5),837-849","journal-title":"RNA"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/267178a0","volume":"267","author":"Rose K.M.","year":"1977","unstructured":"Rose K.M.; Bell L.E.; Jacob S.T.; Specific inhibition of chromatin-associated poly(A) synthesis in vitro by cordycepin 5\u2032-triphosphate. Nature 1977,267(5607),178-180","journal-title":"Nature"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.aivir.2016.08.001","author":"Nakagawa K.","year":"2016","unstructured":"Nakagawa K.; Lokugamage K.G.; Makino S.;  Advances in Virus Research 2016,165-192","journal-title":"Advances in Virus Research"},{"key":"ref=42","author":"V\u2019kovski P.","unstructured":"V\u2019kovski P.; Kratzel A.; Steiner S.; Stalder H.; Thiel V.;  In: Nature Reviews Microbiology; Nature\tResearch, 2020; 19, pp 155-170","journal-title":"In: Nature Reviews Microbiology; Nature\tResearch, 2020; 19, pp 155-170"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"6699","DOI":"10.1073\/pnas.78.11.6699","volume":"78","author":"Doetsch P.W.","year":"1981","unstructured":"Doetsch P.W.; Suhadolnik R.J.; Sawada Y.; Mosca J.D.; Flick M.B.; Reichenbach N.L.; Dang A.Q.; Wu J.M.; Charubala R.; Pfleiderer W.; Henderson E.E.; Core (2\u2032-5\u2032)oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferon. Proc Natl Acad Sci USA 1981,78(11),6699-6703","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"866","DOI":"10.18632\/oncoscience.110","volume":"1","author":"Ryu E.","year":"2014","unstructured":"Ryu E.; Son M.; Lee M.; Lee K.; Cho J.Y.; Cho S.; Lee S.K.; Lee Y.M.; Cho H.; Sung G.H.; Kang H.; Cordycepin is a novel chemical suppressor of Epstein-Barr virus replication. Oncoscience 2014,1(12),866-881","journal-title":"Oncoscience"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1073\/pnas.71.5.2008","volume":"71","author":"Lonai P.","year":"1974","unstructured":"Lonai P.; Decl\u00e8ve A.; Kaplan H.S.; Spontaneous induction of endogenous murine leukemia virus-related antigen expression during short-term in vitro incubation of mouse lymphocytes. Proc Natl Acad Sci USA 1974,71(5),2008-2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1021\/bi00222a004","volume":"30","author":"M\u00fcller W.E.","year":"1991","unstructured":"M\u00fcller W.E.; Weiler B.E.; Charubala R.; Pfleiderer W.; Leserman L.; Sobol R.W.; Suhadolnik R.J.; Schr\u00f6der H.C.; Cordycepin analogues of 2\u2032,5\u2032-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase. Biochemistry 1991,30(8),2027-2033","journal-title":"Biochemistry"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/newbio243172a0","volume":"243","author":"Mahy B.W.J.","year":"1973","unstructured":"Mahy B.W.J.; Cox N.J.; Armstrong S.J.; Barry R.D.; Multiplication of influenza virus in the presence of cordycepin, an inhibitor of cellular RNA synthesis. Nat New Biol 1973,243(127),172-174","journal-title":"Nat New Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1128\/jvi.29.2.811-814.1979","volume":"29","author":"White J.L.","year":"1979","unstructured":"White J.L.; Dawson W.O.; Effect of cordycepin triphosphate on in vitro RNA synthesis by plant viral replicases. J Virol 1979,29(2),811-814","journal-title":"J Virol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0042-6822(83)90204-0","volume":"125","author":"Dawson W.O.","year":"1983","unstructured":"Dawson W.O.; Tobacco mosaic virus protein synthesis is correlated with double-stranded RNA synthesis and not single-stranded RNA synthesis. Virology 1983,125(2),314-322","journal-title":"Virology"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1850352","author":"Verma A.K.","year":"2020","unstructured":"Verma A.K.; Cordycepin: A bioactive metabolite of Cordyceps militaris and polyadenylation inhibitor with therapeutic potential against COVID-19. J Biomol Struct Dyn 2020,1-8","journal-title":"J Biomol Struct Dyn"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/cbdd.13812","volume":"97","author":"Verma A.K.","year":"2021","unstructured":"Verma A.K.; Aggarwal R.; Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm. Chem Biol Drug Des 2021,97(4),836-853","journal-title":"Chem Biol Drug Des"},{"key":"ref=52","unstructured":"Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia - ClinicalTrials Available from:  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00709215"},{"key":"ref=53","author":"Makar S.","unstructured":"Makar S.; Saha T.; Swetha R.; Gutti G.; Kumar A.; Singh S.K.;  Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer. In: Bioorganic Chemistry; Academic Press Inc., 2020; 94, p. 103380."},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ddr.21222","volume":"75","author":"Hung C.L.","year":"2014","unstructured":"Hung C.L.; Chen C.C.; Computational approaches for drug discovery. Drug Development Research, 2014,75,412-418","journal-title":"Drug Development Research,"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.ijbiomac.2020.09.098","volume":"163","year":"2020","unstructured":"Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach. Int J Biol Macromol 2020,163,1787-1797","journal-title":"Int J Biol Macromol"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04502","volume":"6","author":"Ahmad J.","year":"2020","unstructured":"Ahmad J.; Ikram S.; Ahmad F.; Rehman I.U.; Mushtaq M.; SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study. Heliyon 2020,6(7)","journal-title":"Heliyon"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/v12091058","volume":"12","author":"Low Z.Y.","year":"2020","unstructured":"Low Z.Y.; Farouk I.A.; Lal S.K.; Drug repositioning: New approaches and future prospects for life-debilitating diseases and the COVID-19 pandemic outbreak. Viruses 2020,12(9),1058","journal-title":"Viruses"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1080\/07391102.2020.1761882","volume":"39","author":"Elfiky A.A.","year":"2020","unstructured":"Elfiky A.A.; SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. J Biomol Struct Dyn 2020,39(9),3204-3212","journal-title":"J Biomol Struct Dyn"},{"key":"ref=59","author":"Berman H.M.","year":"2000","unstructured":"Berman H.M.; Westbrook J.; Feng Z.; Gilliland G.; Bhat T.N.; Weissig H;  Protein Data Bank 235-42. Available from: 2000 https:\/\/pubmed.ncbi.nlm.nih.gov\/10592235\/","journal-title":"Protein Data Bank"},{"key":"ref=60","author":"DeLano W.L.","year":"2020","unstructured":"DeLano W.L.;  The PyMOL Molecular Graphics System 2020","journal-title":"The PyMOL Molecular Graphics System"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"Kim S.","year":"2016","unstructured":"Kim S.; Thiessen P.A.; Bolton E.E.; Chen J.; Fu G.; Gindulyte A.; Han L.; He J.; He S.; Shoemaker B.A.; Wang J.; Yu B.; Zhang J.; Bryant S.H.; PubChem substance and compound databases. Nucleic Acids Res 2016,44(D1),D1202-D1213","journal-title":"Nucleic Acids Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"O\u2019Boyle N.M.","year":"2011","unstructured":"O\u2019Boyle N.M.; Banck M.; James C.A.; Morley C.; Vandermeersch T.; Hutchison G.R.; Open Babel: An open chemical toolbox. J Cheminform 2011,3(10),33","journal-title":"J Cheminform"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017,7(1),42717","journal-title":"Sci Rep"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"Banerjee P.","year":"2018","unstructured":"Banerjee P.; Eckert A.O.; Schrey A.K.; Preissner R.; ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 2018,46(W1),W257-W263","journal-title":"Nucleic Acids Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2009","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2009,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=66","year":"2020","unstructured":"Desmond Molecular Dynamics System, DE MaestroDesmond Interoperability Tools 2020","journal-title":"Desmond Molecular Dynamics System, DE MaestroDesmond Interoperability Tools"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"Harder E.","year":"2016","unstructured":"Harder E.; Damm W.; Maple J.; Wu C.; Reboul M.; Xiang J.Y.; Wang L.; Lupyan D.; Dahlgren M.K.; Knight J.L.; Kaus J.W.; Cerutti D.S.; Krilov G.; Jorgensen W.L.; Abel R.; Friesner R.A.; OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput 2016,12(1),281-296","journal-title":"J Chem Theory Comput"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1063\/1.449071","volume":"83","year":"1985","unstructured":"D. J. Evans BLH. The Nose-Hoover thermostat. J Chem Phys 1985,83(8),4069-4074","journal-title":"J Chem Phys"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"Xue L.C.","year":"2016","unstructured":"Xue L.C.; Rodrigues J.P.; Kastritis P.L.; Bonvin A.M.; Vangone A.; PRODIGY: A web server for predicting the binding affinity of protein-protein complexes. Bioinformatics 2016,32(23),3676-3678","journal-title":"Bioinformatics"},{"key":"ref=70","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2124","volume":"7","author":"Vangone A.","year":"2017","unstructured":"Vangone A.; Bonvin A.; PRODIGY: A Contact-based Predictor of Binding Affinity in Protein-protein Complexes. Bio Protoc 2017,7(3)","journal-title":"Bio Protoc"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","volume":"111","author":"Subissi L.","year":"2014","unstructured":"Subissi L.; Posthuma C.C.; Collet A.; Zevenhoven-Dobbe J.C.; Gorbalenya A.E.; Decroly E.; Snijder E.J.; Canard B.; Imbert I.; One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proc Natl Acad Sci USA 2014,111(37),E3900-E3909","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251801","volume":"16","author":"Koulgi S.","year":"2021","unstructured":"Koulgi S.; Jani V.; Uppuladinne V.N.M.; Sonavane U.; Joshi R.; Natural plant products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute Respiratory Syndrome Coronavirus-2. PLoS One 2021,16(5)","journal-title":"PLoS One"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/195752","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/195752\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/195752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T05:25:06Z","timestamp":1643779506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/195752\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867328666210820114025","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}